CINECA IRIS Institutional Research Information System

PIVA, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.476
EU - Europa 3.457
AS - Asia 1.708
AF - Africa 37
SA - Sud America 25
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.719
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.402
CN - Cina 813
IT - Italia 786
DE - Germania 607
SG - Singapore 427
IE - Irlanda 354
SE - Svezia 329
UA - Ucraina 309
KR - Corea 235
FR - Francia 218
FI - Finlandia 192
AT - Austria 191
GB - Regno Unito 156
PL - Polonia 76
DK - Danimarca 74
CA - Canada 71
VN - Vietnam 57
IN - India 43
JP - Giappone 40
SN - Senegal 30
BE - Belgio 28
ES - Italia 27
NL - Olanda 26
ID - Indonesia 25
HK - Hong Kong 19
BR - Brasile 18
CH - Svizzera 14
RO - Romania 11
AU - Australia 10
GR - Grecia 10
CZ - Repubblica Ceca 8
BY - Bielorussia 7
RU - Federazione Russa 7
AR - Argentina 6
IR - Iran 6
TH - Thailandia 6
TW - Taiwan 6
MO - Macao, regione amministrativa speciale della Cina 5
PH - Filippine 5
RS - Serbia 5
SA - Arabia Saudita 5
EG - Egitto 4
NO - Norvegia 4
SK - Slovacchia (Repubblica Slovacca) 4
TR - Turchia 4
BG - Bulgaria 3
EU - Europa 3
LT - Lituania 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
PT - Portogallo 3
HR - Croazia 2
HU - Ungheria 2
MX - Messico 2
MY - Malesia 2
NG - Nigeria 2
UZ - Uzbekistan 2
BA - Bosnia-Erzegovina 1
CO - Colombia 1
CY - Cipro 1
JM - Giamaica 1
KW - Kuwait 1
LB - Libano 1
MA - Marocco 1
OM - Oman 1
PS - Palestinian Territory 1
Totale 9.719
Salva come PNG Salva come JPEG
Città #
Chandler 578
Beijing 472
Dublin 354
Singapore 338
Santa Clara 292
Torino 254
Ann Arbor 228
Jacksonville 208
Ashburn 198
Houston 196
Fairfield 192
Vienna 151
Villeurbanne 130
Nyköping 129
Wilmington 125
Princeton 105
Medford 102
Columbus 99
Woodbridge 93
Dearborn 85
Warsaw 75
Turin 74
Milan 72
Boston 65
Cambridge 64
Redwood City 53
Seattle 49
Fremont 48
Pisa 48
Shanghai 46
Dong Ket 41
Boardman 38
Guangzhou 33
New York 32
Verona 31
Nanjing 25
Novara 25
Ottawa 25
Jakarta 24
Brussels 22
San Mateo 18
Norwalk 16
Toronto 16
Hangzhou 14
Jinan 13
Lachine 13
Xian 13
Bologna 12
Helsinki 12
Nürnberg 12
San Diego 12
Tokyo 12
Chengdu 11
Hefei 11
Los Angeles 11
Cleveland 10
Pune 10
Wuhan 10
Barcelona 9
Kunming 9
Paris 9
Rome 9
Zhengzhou 9
Leiden 8
Munich 8
Nanchang 8
Phoenix 8
Washington 8
Chicago 7
Düsseldorf 7
Falls Church 7
Fuzhou 7
Philadelphia 7
Rochester 7
Berlin 6
Hong Kong 6
Modena 6
Mountain View 6
Mumbai 6
Padova 6
San Francisco 6
Shenyang 6
Thening 6
Amsterdam 5
Dallas 5
Des Moines 5
Durham 5
Heidelberg 5
Lappeenranta 5
Rockville 5
Seoul 5
São Paulo 5
Upper Marlboro 5
Birmingham 4
Bratislava 4
Brisbane 4
Camden 4
Ferrara 4
Hamburg 4
Kharkiv 4
Totale 5.704
Salva come PNG Salva come JPEG
Nome #
PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas. 524
IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies 405
PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma. 367
Mutations in NOTCH1 PEST-domain orchestrate CCL19-driven homing of Chronic Lymphocytic Leukemia cells by modulating the tumor suppressor gene DUSP22 326
Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphoma. 253
p130Cas mediates the transforming properties of the anaplastic lymphoma kinase 252
The Krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma. 237
PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p 229
The RNA-binding protein ESRP1 promotes human colorectal cancer progression 215
STAT3-mediated activation of microRNA cluster 17~92 promotes proliferation and survival of ALK positive anaplastic large cell lymphoma. 185
ALK Signaling and Target Therapy in Anaplastic Large Cell Lymphoma 176
SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response 172
IRF4 Mediates the Oncogenic Effects of STAT3 in Anaplastic Large Cell Lymphomas 167
Identification of a new subclass of ALK negative ALCL expressing aberrant levels of ERBB4 transcripts 163
The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma 156
Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphoma 144
Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma 142
Anaplastic lymphoma kinase in human cancer 126
The heterogeneous landscape of ALK negative ALCL 121
A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation 114
Wiskott–Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma 114
Anaplastic large-cell lymphoma 111
bcl-2 protein expression in aged brain and neurodegenerative diseases. 110
ALK expression favorably impacts the prognosis of NRAS-mutated metastatic melanomas 106
Genomic and functional approaches as powerful tools to stratify human T-cell lymphoproliferative disorders and to identify relevant tumorigenic culprits 103
p140Cap protein suppresses tumour cell properties, regulating Csk and Src kinase activity 100
CD30 expression in anaplastic large cell lymphomas is dependent on ALK tyrosine kinase activity via Stat3 phosphorylation and JunB upregulation 98
MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma 97
BRAF-mediated NAMPT overexpression induces a melanoma cell dedifferentiation program leading to metabolic reprogramming and intrinsic resistant to BRAF inhibitors 96
Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death 94
ALK-dependent control of hypoxia-inducible factors mediates tumor growth and metastasis 94
Therapeutic potential of KLF2-induced exosomal microRNAs in pulmonary hypertension 93
Nampt over-expression recapitulates the braf inhibitor resistant phenotype plasticity in melanoma 93
15-Deoxy-delta 12,14-prostaglandin J2 induces apoptosis in human malignant B cells: an effect associated with inhibition of NF-kappa B activity and down-regulation of antiapoptotic proteins 91
Ablation of oncogenic ALK is a viable therapeutic approach fAblation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas 90
Nuclear Akt2 opposes limbal keratinocyte stem cell self-renewal by repressing a FOXO-mTORC1 signaling pathway. 89
Unveiling the pathogenetic role of Stat3 in human lymphoma 87
Molecular anatomy of peripheral T cell lymphomas 86
Mutations in NOTCH1 PEST Domain Orchestrate CCL19-Driven Homing of Chronic Lymphocytic Leukemia (CLL) Cells By Modulating the Gene DUSP22 85
Dissection of critical pathways instrumental for Anaplastic Lymphoma Kinase transformation 82
Activated p38MAPK is a novel component of the intracellular inclusions found in human amyotrophic lateral sclerosis and mutant SOD1 transgenic mice 81
Wild-type idh enzymes as actionable targets for cancer therapy 81
Next Generation Sequencing (NGS) Strategies for Genetic Testing of Cerebral Cavernous Malformation (CCM) Disease 81
Identification of molecular classifiers and key signalling networks in T-cell lymphoproliferative disorders through gene expression profiling meta-analyses 80
c-Jun, JNK/SAPK kinases and transcription factor NF-kappa B are selectively activated in astrocytes, but not motor neurons, in amyotrophic lateral sclerosis. 79
Identification of genomic and proteomic signatures in lymphomas by inducible shRNA 79
Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes 79
NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors. 76
Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis. 74
Dissection of critical pathways instrumental to the Anaplastic Lymphoma Kinase oncogenic activity 73
CDKN2/p16 inactivation and p16 immunohistochemistry in astrocytic gliomas. 72
S-phase kinase-associated protein 2 expression in non-Hodgkin's lymphoma inversely correlates with p27 expression and defines cells in S phase 72
p27/kip1 expression in oligodendrogliomas and its possible prognostic role. 71
A cell cycle alteration precedes apoptosis of granule cell precursors in the weaver mouse cerebellum. 71
Transposable elements: The enemies within 69
Anaplastic large cell lymphoma: one or more entities among T-cell lymphoma? 68
CEP-18770: a novel orally-active proteasome inhibitor with a tumor-selective pharmacological profile competitive with bortezomib 67
Targeting oncogenic ALK by stable small interfering RNA induces cell death of human Anaplastic Large Cell Lymphoma cells 67
The anaplastic lymphoma kinase in the pathogenesis of cancer 67
S-100beta protein is upregulated in astrocytes and motor neurons in the spinal cord of patients with amyotrophic lateral sclerosis. 66
Targeting oncogenic ALK by lentiviral small interfering RNA induces growth arrest and apoptosis of human anaplastic large cell lymphoma cells 64
Gene Expression Profiling Uncovers Molecular Classifiers for theRecognition of Anaplastic Large-Cell Lymphoma Within Peripheral T-Cell Neoplasms 64
Role of apoptosis in the prognosis of oligodendrogliomas 63
Network-based inference of tumorogenic culprits in human T-cell lymphoproliferative disorders 62
Cell-cycle inhibitor p27/Kip-1 expression in non-astrocytic and non-oligodendrocytic human nervous system tumors. 60
Essential role of PDK1 in regulating endothelial cell migration 60
Network-based inference of ALK oncogenic signaling in T-cell lymphoproliferative disorders 59
p27/Kip.1 ubiquitin ligase subunit skp2 relationships with cell proliferation and p27/Kip.1 expression in gliomas 56
Specific Induction of Akt3 in Spinal Cord Motor Neurons is Neuroprotective in a Mouse Model of Familial Amyotrophic Lateral Sclerosis. 56
Targeting oncogenic ALK by lentiviral small interfering RNA induces growth arrest and apoptosis of human Anaplastic Large Cell Lymphoma cells 55
Gene expression profiling uncovers molecular classifiers for the recognition of Anaplastic Large Cell Lymphoma within Peripheral T-cell neoplasms 55
Identification and validation of the anaplastic large cell lymphoma signature 54
The expression signature of Anaplastic Large Cell Lymphomas: from cell line to primary tumors 54
Isolation and characterization of sphere-forming cells from a gliosarcoma patient 53
Molecular events underlying interleukin-6 independence in a subclone of the CMA-03 multiple myeloma cell line. 52
Hypermethylation-Mediated Silencing of CIDEA, MAL and PCDH17 Tumour Suppressor Genes in Canine DLBCL: From Multi-Omics Analyses to Mechanistic Studies 52
IL-6, but not IFN-gamma, triggers apoptosis and inhibits in vivo growth of human malignant T cells on STAT3 silencing 50
In vivo interference with Skp1 function leads to genetic instability and neoplastic transformation. 50
In situ hybridization analysis of Girk2 expression in the developing central nervous system in normal and weaver mice. 48
New and old functions of STAT3: a pivotal target for individualized treatment of cancer 47
Expression of angiopoietin-1 in human glioblastomas regulates tumor-induced angiogenesis: in vivo and in vitro studies. 45
Inverse relationship between p27/Kip.1 and the F-box protein Skp2 in human astrocytic gliomas by immunohistochemistry and Western blot. 44
Lentiviral vectors carrying enhancer elements of Hb9 promoter drive selective transgene expression in mouse spinal cord motor neurons. 44
Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition 43
Induction of apoptosis in estrogen receptor-negative breast cancer cells by natural and synthetic cyclopentenones: role of the IkappaB kinase/nuclear factor-kappaB pathway 42
Muscle apoptosis in humans occurs in normal and denervated muscle, but not in myotonic dystrophy, dystrophinopathies or inflammatory disease. 42
Characterization of murine Girk2 transcript isoforms: structure and differential expression. 41
Low expression of p27 and low proliferation index do not correlate in hairy cell leukaemia. 41
Cyclin D1 expression in gliomas 40
Hypoxia transcriptionally induces macrophage-inflammatory protein-3{alpha}/CCL-20 in primary human mononuclear phagocytes through nuclear factor (NF)-{kappa}B 40
Proteasome-dependent degradation of p27/kip1 in gliomas. 40
Diverse cell death pathways result from a single missense mutation in weaver mouse. 38
The landscape of signaling pathways and proteasome inhibitors combinations in multiple myeloma 37
p27/kip1 expression in human astrocytic gliomas. 37
NF-kappaB: a stress-regulated switch for cell survival 35
p27/kip1 expression in oligodendrogliomas and its possible prognostic role 35
Pathobiology of anaplastic large cell lymphoma. 34
Heat stress triggers apoptosis by impairing NF-kappaB survival signaling in malignant B cells 33
Lack of apoptosis in mice with ALS. 33
Molecular Profiling Improves Classification and Prognostication of Nodal Peripheral T-Cell Lymphomas: Results of a Phase III Diagnostic Accuracy Study. 33
Totale 9.757
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.203
article - articoli 0
book - libri 0
conference - conferenze 4.657
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.860
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020845 0 0 0 0 0 180 154 84 133 110 108 76
2020/20211.125 110 64 77 46 124 50 135 41 134 125 105 114
2021/20221.166 55 60 46 111 53 46 60 53 36 117 293 236
2022/20231.721 187 178 40 178 138 426 118 77 206 42 76 55
2023/2024846 114 138 43 28 57 134 32 62 14 43 68 113
2024/20251.119 30 166 106 223 491 103 0 0 0 0 0 0
Totale 10.009